Plocamium Holdings

Description

Plocamium Holdings — third-generation family office deploying patient capital into operationally complex businesses across healthcare technology, defense, and industrial manufacturing. Lower middle market ($10M–$500M EV). We invest where regulatory friction, geopolitical uncertainty, and operational intensity repel institutional capital — creating asymmetric opportunity. Named for marine algae that thrives in hostile waters, we anchor where others won't. Direct equity — control and significant minority positions in complex, underloved businesses where domain expertise is the barrier to entry. Operational transformation — post-close margin expansion driven by hands-on execution. We run the playbook ourselves. Post-merger integration — acquisitions, carve-outs, and the structural work most firms avoid. Strategic advisory — transaction diligence and value creation for owners navigating complexity or preparing for exit. HQ: New York City. Active across North America, Latin America, and GCC — with depth in Mexican manufacturing and nearshoring where information asymmetry still exists. Sectors: Healthcare technology · Defense & national security · Industrial manufacturing 70+ years of institutional heritage. No thesis drift. No trend-chasing. Durable value creation in segments the market misprices because they're hard. Platforms: RDLB (brand positioning & M&A communications) · 1nessAgency (healthcare digital marketing)

Financials